SCHEMBL4841971

SCHEMBL4841971

COc1ccc2c(c1)/C(=C/C(=O)c1cccc(NS(=O)(=O)c3ccc([N+](=O)[O-])cc3)c1)NC(C)(C)C2

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 5/20 0.47
KMT2A Q03164 5/20 0.47
LMNA P02545 5/20 0.47
SMN1; SMN2 Q16637 4/20 0.47
HTT P42858 4/20 0.47
MAPT P10636 3/20 0.47
KDM4E B2RXH2 3/20 0.47
ALDH1A1 P00352 3/20 0.47
HPGD P15428 2/20 0.47
ALOX12 P18054 1/20 0.47
NPSR1 Q6W5P4 1/20 0.47
TCF4 P15884 1/20 0.46
CTNNB1 P35222 1/20 0.46
GAA P10253 2/20 0.44
KDM1A O60341 2/20 0.42
MAOA P21397 2/20 0.42
CYP19A1 P11511 1/20 0.41
MAPK1 P28482 1/20 0.40
PKM P14618 1/20 0.40
P4HB P07237 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4841981 1.00 MEN1 (0.47) MEN1KMT2ALMNASMN1; SMN2HTT
SCHEMBL4835335 0.92 TCF4 (0.49) MEN1KMT2ALMNASMN1; SMN2HTT
SCHEMBL4835345 0.92 TCF4 (0.49) MEN1KMT2ALMNASMN1; SMN2HTT
SCHEMBL4840956 0.91 SMN1; SMN2 (0.43) MEN1KMT2ALMNASMN1; SMN2HTT
SCHEMBL4840963 0.91 SMN1; SMN2 (0.43) MEN1KMT2ALMNASMN1; SMN2HTT
SCHEMBL4843851 0.91 TCF4 (0.48) MEN1KMT2ALMNASMN1; SMN2HTT
SCHEMBL4843842 0.91 TCF4 (0.48) MEN1KMT2ALMNASMN1; SMN2HTT
SCHEMBL4844620 0.90 TCF4 (0.47) MEN1KMT2ALMNASMN1; SMN2HTT
SCHEMBL4844632 0.90 TCF4 (0.47) MEN1KMT2ALMNASMN1; SMN2HTT
SCHEMBL4840091 0.88 TCF4 (0.46) MEN1KMT2ALMNASMN1; SMN2HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7378428-B2 Nitrogen-containing bicyclic compounds and drugs containing the same as the active ingredient ONO PHARMACEUTICAL CO., LTD. (JP) 2008-05-27 US disclosed
US-20050222138-A1 Nitrogen-containing bicyclic compounds and drugs containing the same as the active ingredient ONO PHARMACEUTICAL CO., LTD. (JP) 2005-10-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050222138-A1 Nitrogen-containing bicyclic compounds and drugs containing the same as the active ingredient PARK7, MMP8, CDK7 MEN1 1230/4885KMT2A 4642/4885LMNA 3014/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.